Invention Grant
- Patent Title: Composition for culturing regulatory T cells and use thereof
-
Application No.: US17743181Application Date: 2022-05-12
-
Publication No.: US11702633B2Publication Date: 2023-07-18
- Inventor: Myoung Ho Jang , Chun-Pyo Hong , Chea Ha Kim , Hye Ri Kim
- Applicant: GI CELL, INC.
- Applicant Address: KR Gyeonggi-do
- Assignee: GI CELL, INC.
- Current Assignee: GI CELL, INC.
- Current Assignee Address: KR Gyeonggi-Do
- Agency: Hultquist, PLLC
- Agent Steven J. Hultquist
- Priority: KR 20190149779 2019.11.20 KR 20200033229 2020.03.18
- Main IPC: C12N5/0783
- IPC: C12N5/0783 ; A61K35/17

Abstract:
The present invention relates to a method for effectively proliferating regulatory T cells, by which, particularly, in the presence of a fusion protein dimer comprising IL-2 protein or a variant thereof and CD80 protein or a fragment thereof, CD4+, CD25+, and CD127− T cells can be effectively proliferated. In particular, when combined with a predetermined cell culture medium, regulatory T cells such as CD4+, CD25+, and CD127− can be effectively and specifically proliferated. In addition, when the method is used, it has been confirmed that the survival rate of regulatory T cells is remarkably increased as compared to a conventionally used culture method using IL-2, and a significant increase in the yield of Foxp3+ regulatory T cells has been confirmed. Thus, such a proliferation method can be used in the field of cell therapeutic agents using regulatory T cells.
Public/Granted literature
- US20220290102A1 COMPOSITION FOR CULTURING REGULATORY T CELLS AND USE THEREOF Public/Granted day:2022-09-15
Information query